<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Marshall | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/magicmotion57/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/magicmotion57/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Marshall.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">97836f13742d589d63ce42d51570ed1e</guid>
				<title>Marshall posted an update: Perilipin 5 (PLIN5) is a lipid-droplet-associated protein [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39973/</link>
				<pubDate>Thu, 06 Feb 2025 11:25:18 -0800</pubDate>

									<content:encoded><![CDATA[<p>Perilipin 5 (PLIN5) is a lipid-droplet-associated protein that coordinates intracellular lipolysis in highly oxidative tissues and is thought to regulate lipid metabolism in response to phosphorylation by protein kinase A (PKA). We sought to identify PKA phosphorylation sites in PLIN5 and assess their functional relevance in cultured cells and the&hellip;<span class="activity-read-more" id="activity-read-more-39973"><a href="http://www.nationalboardinstitute.com/activity/p/39973/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">76e34fba24167426ff44cbade3731166</guid>
				<title>Marshall posted an update: 07, while the average F values were -0.003, -0.01 and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38191/</link>
				<pubDate>Tue, 04 Feb 2025 10:04:21 -0800</pubDate>

									<content:encoded><![CDATA[<p>07, while the average F values were -0.003, -0.01 and -0.003, respectively. The annotation and enrichment analysis, performed in the identified most frequent ROH (TOP_ROH), showed genes that can be linked to the resilience capacity of these populations to harsh environmental farming conditions, and to the peculiar characteristics searched for by&hellip;<span class="activity-read-more" id="activity-read-more-38191"><a href="http://www.nationalboardinstitute.com/activity/p/38191/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b93acca10cd16ae016468a129cbdd799</guid>
				<title>Marshall posted an update: 2, respectively. Leishmania (Leishmania) [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36422/</link>
				<pubDate>Sun, 02 Feb 2025 10:17:58 -0800</pubDate>

									<content:encoded><![CDATA[<p>2, respectively. Leishmania (Leishmania) amazonensis-infected BALB/c mice were given topical doses of SO or SO-NE. The topical use of a combination of SO-NE and intraperitoneal meglumine antimoniate reduced lesion size by 41 % and tissue regeneration was proven by histopathological analyses. In addition, a reduction in the parasitic load and&hellip;<span class="activity-read-more" id="activity-read-more-36422"><a href="http://www.nationalboardinstitute.com/activity/p/36422/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6bbccbd2a7814d6880c8b21b77919da4</guid>
				<title>Marshall posted an update: BACKGROUND Depressive symptoms are common in individuals [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28521/</link>
				<pubDate>Tue, 28 Jan 2025 11:27:09 -0800</pubDate>

									<content:encoded><![CDATA[<p>BACKGROUND Depressive symptoms are common in individuals suffering from severe somatic conditions. There is a lack of interventions and evidence-based interventions aiming to reduce depressive symptoms in patients with severe somatic conditions. The aim of the NEVERMIND project is to address these issues and provide evidence by testing the&hellip;<span class="activity-read-more" id="activity-read-more-28521"><a href="http://www.nationalboardinstitute.com/activity/p/28521/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1fc8cf3e010c10f89470303c98c0d4ee</guid>
				<title>Marshall became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28471/</link>
				<pubDate>Tue, 28 Jan 2025 11:23:50 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>